Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.25 USD | -6.09% | 0.00% | +47.36% |
05-14 | Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-30 | North American Morning Briefing : More Earnings -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.36% | 224M | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- ACRV Stock
- News Acrivon Therapeutics, Inc.
- Acrivon Therapeutics Plans IND Submission for ACR-2316 by Q4 2024